title: [Effect of intraperitoneal furosemide administration on levels of +proteins+ in plasma and signs of their ability to be dialyzed during intermittent peritoneal dialysis].
abstract: The study aimed at evaluating an effect of intraperitoneal furosemide on plasma proteins such as albumins, globulins, IgG and IgA and their loss during dialysis. An experiment involved 18 patients with critical renal failure treated with intermittent peritoneal dialyses. Furosemide was administered intraperitoneally with dialysing fluid (40 mg/1) in a total dose of 240 mg. Each patient underwent 2 dialyses of 14 exchanges each. The first dialysis without furosemide served as a control of plasma protein loss during conventional dialysis with a fluid of 369 mOsm/kg at flow rate 2.4 l/hour. Furosemide was given during the second dialysis during three consecutive exchanges. An effect of furosemide on plasma proteins was compared with the results obtained before and after its administration. It was found that furosemide did not change plasma proteins levels and does not increase their loss during exchanges of dialysing fluid containing this drug; during dialysing fluid exchanges without furosemide some indices of IgG and IgA dialysis are significantly decreased due to an increase in ultrafiltration following furosemide cessation. It is important for the increase in intermittent peritoneal dialyses efficiency with the aid of furosemide that its short-term administration does not increase proteins loss during dialysis, if their molecular weight is not exceeding 69,000.
authors.affiliation: Kliniki Nefrologii Instytutu Chorób Wewnetrznych AM im. K. Marcinkowskiego w Poznaniu.
authors.forename: A
authors.initials: A
authors.lastname: Grzegorzewska
authors.forename: M
authors.initials: M
authors.lastname: Krzymański
authors.forename: K
authors.initials: K
authors.lastname: Antoniewicz
mesh_terms: D000328:Adult; D000368:Aged; D001798:Blood Proteins / Q000187:drug effects* / Q000378:metabolism; D005260:Female; D005665:Furosemide / Q000008:administration & dosage*; D006801:Humans; D007263:Infusions, Parenteral; D007676:Kidney Failure, Chronic / Q000378:metabolism / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D010530:Peritoneal Dialysis
chemical_list: D001798:Blood Proteins; D005665:Furosemide
vernacular_title: Wpływ dootrzewnego podania furosemidu na stezenie białek w osoczu i wskaźniki ich dializacyjności podczas przerwanej dializy otrzewnowej.